A practical scoring system to determine whether to proceed with surgical resection in recurrent glioblastoma

Neuro-Oncology

Volumn 15, Issue 8, 2013, Pages 1096-1101

  Park, Chul Kee ^a   Kim, Jeong Hoon ^b   Nam, Do Hyun ^c   Kim, Chae Yong ^d   Chung, Sang Bong ^c   Kim, Young Hoon ^d   Seol, Ho Jun ^c   Kim, Tae Min ^a   Choi, Seung Hong ^a   Lee, Se Hoon ^a   Heo, Dae Seog ^a   Kim, Il Han ^a   Kim, Dong Gyu ^a   Jung, Hee Won ^a  

^a Seoul National University Hospital   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

^d Seoul National University Bundang Hospital   (South Korea)

Author keywords

ependymal involvement; performance status; recurrent glioblastoma; scoring system; surgery

Indexed keywords

NIMUSTINE; NITROSOUREA DERIVATIVE; TEMOZOLOMIDE;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CRANIOTOMY; FEMALE; GLIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NIH RECURRENT GBM SCALE; NUCLEAR MAGNETIC RESONANCE; RECURRENT CANCER; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SCORING SYSTEM; SURVIVAL TIME;

EPENDYMAL INVOLVEMENT; PERFORMANCE STATUS; RECURRENT GLIOBLASTOMA; SCORING SYSTEM; SURGERY;

ADULT; AGED; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; DECISION SUPPORT TECHNIQUES; FEMALE; FOLLOW-UP STUDIES; GLIOBLASTOMA; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NOMOGRAMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REOPERATION; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84880655281     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/not069     Document Type: Article

References (19)

1. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987-996. (Pubitemid 40349501)
2. Albert FK, Forsting M, Sartor K, Adams HP, Kunze S. Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery. 1994;34:45-60; discussion 60-41.
3. Jeremic B, Grujicic D, Antunovic V, et al. Influence of extent of surgery and tumor location on treatment outcome of patients with glioblastoma multiforme treated with combined modality approach. J Neurooncol. 1994;21:177-185. (Pubitemid 24313780)
4. Lacroix M, Abi-Said D, Fourney DR, et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg. 2001;95:190-198. (Pubitemid 32799739)
5. Simpson JR, Horton J, Scott C, et al. Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. Int J Radiat Oncol Biol Phys. 1993;26:239-244. (Pubitemid 23156970)
6. Vecht CJ, Avezaat CJ, van Putten WL, Eijkenboom WM, Stefanko SZ. The influence of the extentofsurgeryonthe neurological function and survival in malignant glioma. A retrospective analysis in 243 patients. J Neurol Neurosurg Psychiatry. 1990;53:466-471. (Pubitemid 20189579)
7. Stummer W, Pichlmeier U, Meinel T, et al. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol. 2006;7:392-401.
8. Ammirati M, Galicich JH, Arbit E, Liao Y. Reoperation in the treatment of recurrent intracranial malignant gliomas. Neurosurgery. 1987;21: 607-614. (Pubitemid 18001496)
9. Barker FG 2nd, Chang SM, Gutin PH, et al. Survival and functional status after resection of recurrent glioblastoma multiforme. Neurosurgery. 1998;42:709-720; discussion 720-703.
10. Dirks P, Bernstein M, Muller PJ, Tucker WS. The value of reoperation for recurrent glioblastoma. Can J Surg. 1993;36:271-275. (Pubitemid 23248140)
11. Harsh GR 4th, Levin VA, Gutin PH, et al. Reoperation for recurrent glioblastoma and anaplastic astrocytoma. Neurosurgery. 1987;21:615-621. (Pubitemid 18001497)
12. Park JK, Hodges T, Arko L, et al. Scale to predict survival after surgery for recurrent glioblastoma multiforme. J Clin Oncol. 2010;28:3838-3843.
13. Xu T, Chen J, Lu Y. Recurrent glioblastoma: not only surgery. J Clin Oncol. 2011;29:e102-e103.
14. Komotar RJ, Starke RM, Connolly ES, Sisti MB. Evaluating the benefit of repeat surgery for recurrent glioblastoma multiforme. Neurosurgery. 2010;67:N16-17.
15. Macdonald DR, Cascino TL, Schold SC Jr, Cairncross JG. Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol. 1990;8:1277-1280. (Pubitemid 20195640)
16. Lamborn KR, Chang SM, Prados MD. Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis. Neuro Oncol. 2004;6:227-235. (Pubitemid 39136506)
17. Lim DA, Cha S, Mayo MC, et al. Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype. Neuro Oncol. 2007;9:424-429.
18. Bohman LE, Swanson KR, Moore JL, et al. Magnetic resonance imaging characteristicsofglioblastoma multiforme: implications for understanding glioma ontogeny. Neurosurgery. 2010;67:1319-1327; discussion 1327-1318.
19. Young GS, Macklin EA, Setayesh K, et al. Longitudinal MRI evidence for decreased survival among periventricular glioblastoma. J Neurooncol. 2011;104:261-269.